Stryker Recalls Vitagel Surgical Hemostat Due to Cold Chain Violations
Stryker Orthobiologics is recalling Vitagel surgical hemostat shipments that were not delivered within validated timeframes, potentially compromising the product's required cold storage.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the source text describes a cold chain violation without reporting any specific illnesses, injuries, or deaths. This aligns with the rubric for moderate severity involving low-risk contamination or voluntary precautionary measures where harm has not been reported.
Plain-English summary
Orthovita, Inc., dBA Stryker Orthobiologics, is recalling 274 units of Vitagel, a surgical hemostat indicated as an adjunct to hemostasis in surgical procedures. The recall involves specific product numbers (2113-0000, 2113-0202, 2113-0205) and lot numbers (A1407061, A1406053, A1410055, A1501033, A1407037, A1412010, A1412076) with expiry dates ranging from August 2016 to March 2017.
The recall was initiated because several shipments of Vitagel, which requires storage at 2 to 8 degrees Celsius, were not delivered to customers within the validated delivery time. This deviation from the required cold chain may affect the product's integrity. The affected units were distributed nationwide, including in New York, Pennsylvania, West Virginia, Michigan, Illinois, Massachusetts, Texas, Arkansas, Kansas, Florida, Wisconsin, California, Missouri, Louisiana, Virginia, Iowa, Ohio, and North Carolina.
Healthcare facilities and distributors should stop using the affected Vitagel units and contact the recalling firm for instructions on return or disposal. Consumers are not directly affected as this is a professional medical device used in surgical settings.
The recalled product
- Product
- Vitagel; indicated in surgical procedures (other than in neurosurgical and ophthalmic) as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.
- Manufacturer
- Orthovita, Inc., dBA Stryker Orthobiologics.
- Affected units
- 274
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (16)
- Product Numbers: 2113-0000
- 2113-0202
- 2113-0205
- Lot Numbers: A1407061
- A1406053
- A1410055
- A1501033
- A1407037
- A1412010
- A1412076
- Expiry Dates: 02/28/2017
- 08/31/2016
- 03/31/2017
- 10/31/2016
- 01/31/2017
- 09/30/2016
Distribution
Related recalls
Same manufacturer · Orthovita, Inc., dBA Stryker Orthobiologics.
See all →- HighStryker Orthobiologics Recalls Aliquot Delivery Kits Due to Packaging Defects
FDA (Devices) · 2015-09-23
- ModerateStryker Orthobiologics Recalls Imbibe Bone Marrow Aspiration Needles
FDA (Devices) · 2015-01-14
- ModerateStryker Orthobiologics Imbibe Aliquot Needle Bone Cement Needle Recall
FDA (Devices) · 2015-01-14
- ModerateStryker Orthobiologics Aliquot Plunger Delivery System Recalled for Catheter Breakage
FDA (Devices) · 2013-06-05
- ModerateStryker Orthobiologics Aliquot Diamond Needle Recall for Catheter Breakage
FDA (Devices) · 2013-06-05